Disease | crohn disease |
Symptom | C0027121|myositis |
Sentences | 2 |
PubMedID- 23556424 | We report the use of adalimumab (abbott, canada, inc.) for orbital myositis in a patient with crohn's disease who discontinued infliximab (janssen, canada, inc.) and review of the published literature. |
PubMedID- 21575896 | Adalimumab for recurrent orbital myositis in crohn's disease: report of a case with a 3-year follow-up. |
Page: 1